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Rap1 binding and a lipid-dependent helix in talin F1
domain promote integrin activation in tandem
Alexandre R. Gingras1*, Frederic Lagarrigue1*, Monica N. Cuevas1, Andrew J. Valadez1, Marcus Zorovich1, Wilma McLaughlin1,
Miguel Alejandro Lopez-Ramirez1, Nicolas Seban1, Klaus Ley2,3, William B. Kiosses4, and Mark H. Ginsberg1
Rap1 GTPases bind effectors, such as RIAM, to enable talin1 to induce integrin activation. In addition, Rap1 binds directly to the
talin1 F0 domain (F0); however, this interaction makes a limited contribution to integrin activation in CHO cells or platelets.
Here, we show that talin1 F1 domain (F1) contains a previously undetected Rap1-binding site of similar affinity to that in F0. A
structure-guided point mutant (R118E) in F1, which blocks Rap1 binding, abolishes the capacity of Rap1 to potentiate talin1-
induced integrin activation. The capacity of F1 to mediate Rap1-dependent integrin activation depends on a unique loop in F1 that
has a propensity to form a helix upon binding to membrane lipids. Basic membrane-facing residues of this helix are critical, as
charge-reversal mutations led to dramatic suppression of talin1-dependent activation. Thus, a novel Rap1-binding site and a
transient lipid-dependent helix in F1 work in tandem to enable a direct Rap1–talin1 interaction to cause integrin activation.
Introduction
Integrin receptors are critical mediators of cellular adhesion,
migration, and assembly of the extracellular matrix, thereby
playing an indispensable role in development and in many
pathological processes (Hynes, 2002). Regulation of the affinity
of integrins for their ligands is central to their function. In
particular, integrins in blood cells are usually expressed in a
low-affinity form until intracellular signals initiated by agonists
acting via distinct excitatory receptors induce a high-affinity
state, a process operationally defined as integrin activation.
Binding of talin1 to the cytoplasmic tail of integrin β1 (Tadokoro
et al., 2003; Shattil et al., 2010), β2 (Simonson et al., 2006), β3
(Nieswandt et al., 2007; Petrich et al., 2007a,b; Haling et al.,
2011), and β7 (Sun et al., 2018) is a critical final common step
in integrin activation.
Talin1 is a large (270-kD) multidomain protein that links
integrins to the actin cytoskeleton via its N-terminal head do-
main that binds to the β-integrin cytoplasmic tail and its
C-terminal flexible rod domain that binds F-actin (Critchley and
Gingras, 2008). The talin1 head domain (THD) comprises an
atypical FERM (4.1 protein, ezrin, radixin, and moesin) domain,
because it contains an additional F0 domain to the characteristic
FERM F1, F2, and F3 domains and can adopt a linear arrange-
ment rather than the cloverleaf structure typically observed in
other FERM domains (Calderwood et al., 2013). Talin1 is auto-
inhibited in the cytosol due to the interaction of the THD with
the rod domain, which prevents the interaction of THD with the
integrin β cytoplasmic tail (Song et al., 2012). Our understanding
of the signaling events that regulate talin1 recruitment to
the plasma membrane and its association with integrin is
incomplete.
Rap1 GTPases are perhaps the most completely studied relays
of signals from cell surface receptors to integrin activation.
Combined deficiency of both Rap1A and Rap1B isoforms in the
megakaryocyte lineage showed an essential role for Rap1 sig-
naling in platelet integrin activation and function (Stefanini
et al., 2018). Although the Rap1 effector Rap1-GTP–interacting
adapter molecule (RIAM) plays a major role in recruiting talin1
in leukocytes (Klapproth et al., 2015; Su et al., 2015; Lagarrigue
et al., 2017), its role in talin1-dependent activation of platelet
integrins has been unequivocally ruled out (Klapproth et al.,
2015; Stritt et al., 2015; Su et al., 2015).
Studies using recombinant αIIbβ3-expressing A5 CHO cells
revealed that Rap1 activity regulates THD-induced integrin
αIIbβ3 activation (Lagarrigue et al., 2018), while activation by
the F2F3 subdomain is Rap1 independent (Han et al., 2006). This
result suggests that a direct interaction between Rap1 and the
F0F1 domains facilitates integrin activation. Structural studies
showed that Rap1b binds directly to F0 with low affinity (Goult
et al., 2010). Furthermore, in Dictyostelium discoideum Rap1 di-
rectly interacts with the Ras-associating (RA) domain of talinB
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(Plak et al., 2016) to enable adhesion during D. discoideum mor-
phogenesis. Similarly, a mutation in F0 that inhibits Rap1
binding is embryonic lethal in Drosophila melanogaster (Camp
et al., 2018). Zhu et al. (2017) confirmed the direct Rap1–talin1
F0 interaction and showed that membrane-anchored Rap1b in
vesicles has enhanced binding to THD, suggesting a mechanism
of talin1 recruitment to integrins by Rap1. Quantitative proteo-
mic analyses of murine platelets revealed the high abundance of
Rap1b and talin1 (Zeiler et al., 2014). The abundance of the
proteins at equal molar ratios and the lack of a known Rap1 ef-
fector with such a high abundance in platelets suggest that F0
may act as a direct effector of Rap1 to activate integrins in pla-
telets. However, we recently reported a talin1 point mutation
(R35E) in F0 domain that reduces Rap1 affinity by >25-fold does
not impair the capacity of THD to activate integrins in A5 cells
nor does it abolish effects of Rap1 activity on THD-induced
activation. In accord with this result, we and others
(Bromberger et al., 2018) found that mice with F0 mutations
that disrupt Rap1 binding are viable, fertile, and apparently
healthy and exhibit similar or slightly reduced extent and
kinetics of αIIbβ3 activation (Lagarrigue et al., 2018). These
mice did manifest a mild defect in platelet aggregation and he-
mostasis. Thus, the low-affinity Rap1–talin1 F0 interaction does
not make a major contribution to integrin αIIbβ3 activation in
mice and cannot account for the profound effects on activation in
RIAM-deficient platelets of (1) loss of Rap1 activity (Stefanini et al.,
2018), (2) deletion of talin1 (Nieswandt et al., 2007; Petrich et al.,
2007b), (3) mutations of integrin β3 that block talin1 binding
(Petrich et al., 2007a), and (4) mutations of talin1 that prevents
binding to integrin β3 (Haling et al., 2011).
Here, we show that F1 contains a previously undiscovered
Rap1-binding site of similar affinity to that in F0. A structure-
guided mutant in F1, which blocks Rap1 binding, abolishes the
capacity of Rap1 to potentiate talin1-induced integrin activation.
Talin1 F1’s ability to mediate Rap1-dependent integrin activation
requires a unique unstructured loop that transforms into an
amphipathic helix upon binding to membrane lipids. Charge-
reversal mutations of basic membrane-facing residues of this
helix profoundly suppressed talin1-dependent activation. Thus,
a novel Rap1 binding site and a transient lipid-dependent helix
in F1 work in tandem to enable a direct Rap1–talin1 interaction to
promote integrin activation.
Results and discussion
THD contains a second Rap1-binding site
Since integrin activation induced by THD(R35E) was still Rap1
dependent (Lagarrigue et al., 2018), we hypothesized that THD
could have a second Rap1-binding site. We used nuclear mag-
netic resonance (NMR) spectroscopy to examine the interaction
of 15N-labeled Rap1b with unlabeled THD. The 2D-HSQC of
Rap1b showed dispersed resonances characteristic of a well-
folded protein (Fig. 1 A). Addition of THD caused extensive
broadening of Rap1b resonances (Fig. 1 B) due to its interaction
with the larger THD. We previously showed that the F0 domain
of talin1(R35E) does not detectably bind Rap1b (Lagarrigue et al.,
2018); however, THD(R35E) caused broadening of the Rap1b
resonances (Fig. 1 C), whereas THD(wt) (Fig. 1 B) caused a more
profound effect. While R35E mutation reduces the affinity dra-
matically, residual binding might still be able to cause broad-
ening. We therefore tested THD(ΔF0), comprising talin1 F1–F3
domains, and found that it bound Rap1 as assessed by interme-
diate broadening (Fig. 1 D), consistent with the reduced mass of
THD(ΔF0). The residual Rap1-binding capacity of THD(R35E)
and THD(ΔF0) combined with the lack of Rap1 dependence of
F2F3-mediated integrin activation (Han et al., 2006) raised
the possibility that THD has a second Rap1-binding site in the
F1 domain.
To assess the contribution of each subdomain in THD in Rap1-
regulated integrin activation, we generated THD deletions by
removing the F0, F1, or F0F1 domains (Fig. 1 E) and tested effects
on integrin activation in A5 cells. THD induced a similar extent
of integrin activation as the addition of manganese (Fig. S1 A),
indicating that THD expression provokes substantial integrin
αIIbβ3 activation in A5 cells. Expression of all three THD mu-
tants induced activation (Fig. 1 F, gray bars), with a markedly
lower activation index for THD(ΔF1) and THD(ΔF0F1), both
lacking the F1 domain. Inhibition of endogenous Rap1 activity by
coexpression of Rap1GAP1 led to a decrease in both THD and
THD(ΔF0)-mediated activation but did not affect activation with
THD mutants lacking the F1 domain (Fig. 1 F, blue bars). Fur-
thermore, expression of the constitutively activated Rap1(Q63E)
mutant trended to increased THD(ΔF0)-mediated αIIbβ3 acti-
vation but had no evident effect on activation with THDmutants
lacking the F1 domain (Fig. 1 F, red bars). Thus, the effect of Rap1
activity on integrin activation by THD(ΔF0) resembles that ob-
served with THD(wt) (Lagarrigue et al., 2018). Immunoblotting
confirmed similar level of expression for all THD mutants
(Fig. 1 G). Because Bromberger et al. (2018) reported a slight
reduction in platelet αIIbβ3 activation by introducing the three
mutations K15A, R30A, and R35A in the F0 domain, we tested
the effect of these mutations on THD-dependent αIIbβ3 integrin
activation in A5 cells and observed no effect (Fig. S1, B–E). Taken
together, these data suggest that talin1 F1 has a second Rap1-
binding site important in integrin activation, a surprising con-
clusion in light of a previous report that the F1 domain does not
bind Rap1b (Zhu et al., 2017).
F1 binds Rap1
Since both F0 and F1 have a ubiquitin fold (Goult et al., 2010), we
aligned their amino acid sequence and noticed that the key
positively charged residues for Rap1 binding are conserved: K15
and R35 in F0 and R98 and R118 in F1 (Fig. 2 A). Moreover, su-
perimposition of the NMR structures of F0 with F1 showed that
the position of these residues is maintained. We therefore gen-
erated a model of the talin1 F1–Rap1 complex by superimposing
F1 with the F0 domain in complex with Rap1b (Zhu et al., 2017).
We found the F1 interface with Rap1b to be very similar to that of
F0, with positively charged R98 and R118 showing surface
charge complementarity with the negatively charged groups on
Rap1 surface (Fig. 2 B). Importantly, using the NMR structure of
F1 alone (Goult et al., 2010), we found the inserted F1 loop to be
positioned far away from the binding interface where it would
not sterically hinder Rap1b binding.
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To test the presence of a Rap1-binding site, we prepared
15N-labeled F1 for NMR studies. The 2D-sofast-HMQC (sfHMQC)
of F1 showed a stable folded protein, with most resonances being
highly dispersed (Fig. 2 C, blue). The presence of sharp intense
signals located in the center of the spectra is consistent with a
35-residue loop that is unstructured and highly dynamic. Ad-
dition of Rap1b caused residue-specific chemical shift changes in
F1 (Fig. 2 C, red), in contrast to the studies of Zhu et al. (2017)
using the F1F2 double domain. As predicted, the nondispersed
resonances from the loop were not affected by Rap1b. Further-
more, we mapped specific chemical shifts, including Arg98 and
Arg118 (Fig. S2 A), that clustered to amino acids located in the
predicted RA binding interface near the F1 β2 strand (Fig. S2 B).
NMR titrations showed concentration-dependent chemical shift
perturbations with fast exchange, that suggested a weak affinity
of F1 for Rap1 based on several amino acids located at the binding
interface (Fig. 2 D and Fig. S2, E–H, blue lines). As highlighted in
Fig. 2 E, the chemical shift perturbations were small and made
the determination of the affinity less accurate. After careful
analysis, we found that the apparent Kd values for the F1–Rap1
interaction varied from the low-to-high micromolar range
(summarized in Fig. S2 C). Analysis of our previous data on F0
Figure 1. THD contains a second Rap1-binding site. (A–D) 2D 1H,15N-sfHMQC spectra of 100 µM 15N-labeled Rap1b. (A) Free Rap1b. (B) Rap1b with 250 µM
THD(wt). The broadening of Rap1 resonances in the presence of THD indicates binding. (C) Rap1b with 250 µM THD(R35E). The broadening indicates the
presence of a second Rap1-binding site. (D) Rap1b with 250 µM THD(ΔF0). The intermediate broadening indicates the second Rap1-binding site outside the F0
domain. (E) THD constructs used in F and G. (F) A5 cells stably expressing αIIbβ3 integrin were transfected with cDNA encoding THD-EGFP in combination with
Rap1(Q63E) or Rap1GAP1. Integrin activation was assayed by binding of PAC1 to EGFP-positive cells. Transfection of EGFP alone was used as control. Bar
graphs represent mean ± SEM of four independent experiments and normalized to THD(wt)-EGFP + mock. Two-way ANOVA with Bonferroni post-test. Each
condition was compared with the respective mock control. *, P < 0.05; ***, P < 0.001. (G) WB of THD-EGFP expression. Actin was used as a loading control.
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Figure 2. F1 also contains a Rap1b-binding site, and the R118E mutation blocks binding to Rap1. (A) Amino acid sequence alignment of the F0 and F1
domains. Invariant residues indicated with and asterisk (*), conserved residues with a colon (:), and semiconserved residues with a period (.). Rap1-binding
residues (blue) are >25% buried by formation of the complex. (B) Surface electrostatic potential of the talin1 F1 (right) and Rap1b (left) binding interface in
open-book view. The dotted black lines highlight the charge complementarity between the two proteins at the binding interface. The location of the F1 loop is
also shown by a gray dotted line. (C) 2D 1H,15N-sfHMQC spectra of 100 µM 15N-labeled talin1 F1 WT (blue) and in the presence of 700 µM GMP.PNP Rap1b
(red). Specific chemical shift changes are observed, indicating binding. (D) Representative titration curves for the interaction of Rap1b with F1 WT in blue and
R118E mutant in red (for more examples, see Fig. S2, E–H). The talin1(R118E) mutation has a dramatic effect on Rap1b binding. (E) Closeup view of the 10-step
Rap1b titration for residues K89, D94, and T96. (F and G) 2D 1H,15N-sfHMQC spectra of 100 µM 15N-labeled talin1 F1. (F)WT (blue) and R118E (red). Almost all
peaks are in the same position, suggesting that THD(R118E) is well folded and has a fold similar to WT protein. (G) Free talin1 F1(R118E) in the absence (blue)
and presence of GMP.PNP Rap1b (red) at 1:7 molar ratio. No chemical shift changes are observed at sevenfold excess Rap1b, suggesting that F1(R118E)
drastically reduced the affinity of the interaction.
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also showed similar variations (Fig. S2 D; Goult et al., 2010;
Lagarrigue et al., 2018), suggesting that this is an intrinsic
property of F0 and F1. Thus, F1 contains an RA domain that can
bind Rap1b to a similar extent as F0 (Goult et al., 2010; Zhu et al.,
2017; Lagarrigue et al., 2018).
Dramatically reduced affinity of talin1(R118E) F1 domain
binding to Rap1
Our molecular modeling suggested that talin1 Arg98 and Arg118
play an important role on the surface charge complementarity
with Rap1b (Fig. 2 B), and the NMR data showed that their
backbone amide chemical shift is affected by binding. We used
the acidic Glu mutation because of the predicted stronger effects
of charge repulsions between F1 and the acidic patch on the
surface of Rap1b that mediates their interaction. We therefore
purified recombinant 15N-labeled F1(R118E) mutant. Comparison
of the NMR 2D-sfHMQC of the F1(wt) and F1(R118E) mutant
showed only very subtle chemical shift changes (Fig. 2 F); thus,
the mutant protein adopts a similar fold to F1(wt). Addition of
GMP.PNP Rap1b to F1(R118E) produced no specific chemical shift
changes (Fig. 2 G), suggesting that it does not bind to Rap1b. The
minimal chemical shift perturbations detected at sevenfold ex-
cess of Rap1b with F1(R118E) indicated a substantial reduction in
Rap1b affinity (Fig. 2 D and Fig. S2, E–H, red lines) as judged by
negligible chemical shift for each previously perturbed residue.
Thus, F1(R118E) is well folded and has a greatly reduced affinity
for Rap1.
Talin1 F1–Rap1b interaction is important for THD-mediated
αIIbβ3 activation in A5 cells
To assess the contribution of the talin1 F0 and F1 interactions
with Rap1 on integrin activation, we introduced the mutations
R35E and R118E and a double mutant (R35E,R118E) into the THD
(Fig. 3 A) and tested effects on integrin activation in A5 cells.
Expression of all THDs induced integrin activation, with
THD(wt) and THD(R35E) producing comparable levels of ac-
tivation. In sharp contrast, both constructs with F1 mutations,
THD(R118E) and THD(R35E,R118E), exhibited a substantially
reduced activation (Fig. 3 B, gray bars). Furthermore, we care-
fully monitored expression of THD-EGFP and its mutants by
flow cytometry and observed a strong effect of the F1 mutants
at equivalent levels of THD expression on a per-cell basis (Fig. 3
C). Immunoblotting confirmed similar level of global expres-
sion for all THD mutants (Fig. 3 D). More importantly, coex-
pression of both Rap1(Q63E) and Rap1GAP1 had no effect on
integrin activation when the R118E mutation was introduced
in the F1 domain (Fig. 3 B, red and blue bars). Also, THD(wt)-
induced activation in the presence of Rap1GAP1 was very similar
to activation with the THD(R118E) mutant alone, further sup-
porting the conclusion that the F1–Rap1 interaction plays a
crucial role in Rap1’s ability to potentiate THD-induced αIIbβ3
activation.
Talin1 F1 loop is important for Rap1 to increase THD-mediated
αIIbβ3 activation
Since both the talin1 F0 and F1 domains contain a Rap1-binding
site with similar affinity for Rap1b in vitro, and because only the
THD(R118E) mutant in F1 had an effect on THD-mediated αIIbβ3
activation, we examined differences between the two domains.
First, the F1 domain is located adjacent to the F2 domain, which
contains a critical membrane-orientation patch required for
activation (Anthis et al., 2009); however, in THD(ΔF1), the F0 is
adjacent to F2 yet THD(ΔF1) exhibits little Rap1 dependence
(Fig. 1 F). Second, the F1 domain contains an unstructured loop
implicated in integrin activation. Goult et al. (2010) showed that
this loop has helical propensity and forms a more stable helix on
binding to phospholipids. Basic residues, predicted to reside on
one surface of the helix, are required for binding to acidic
phospholipids (Goult et al., 2010).
To assess the contribution of both the talin1 F1 loop and the
interaction with Rap1 on integrin activation, we tested integrin
activation by THD wherein the loop was removed, THD(ΔL)
(Fig. 4 A). As previously observed (Goult et al., 2010), THD(ΔL)
reduced integrin activation (Fig. 4 B, gray bars). Importantly,
coexpression of both Rap1(Q63E) and Rap1GAP1 had a negli-
gible effect on integrin activation by THD(ΔL) (Fig. 4 B, red
and blue bars). Furthermore, the effect of the double mutant
THD(ΔL,R118E) resembled that of THD(ΔL). Immunoblotting
confirmed similar level of expression for all THD mutants
(Fig. 4 C). 2D-sfHMQC NMR spectra of 15N-labeled talin1 F1(ΔL)
exhibited highly dispersed resonances consistent with a stable
folded protein (Fig. 4 D, blue). Addition of Rap1b caused residue-
specific chemical shift changes in talin1 F1(ΔL) (Fig. 4 D, red) that
mapped to amino acids located in the predicted RA–binding
interface, including Thr96 and Thr99 (Fig. 4 E). Thus, the talin1
F1 loop is important for Rap1 dependence of THD-mediated
integrin activation, but not for Rap1b binding, indicating that
the F1 loop works in tandem with Rap1 binding in performing
this function.
To further validate the proposed formation of a helix
mechanism whereby the talin1 F1 loop plays a role in integrin
activation, we introduced three charge-reversal mutations
in basic residues on the surface of the predicted helix
(R146E,R153E,K156E (3EL)) to create a charge repulsion with
the negatively charged phosphatidylinositol 4,5-bisphosphate
(PI(4,5)P2) of the plasma membrane (Fig. S3 A) that blocks lipid
binding (Goult et al., 2010). THD(3EL) was even less active
than THD(ΔL) in activating αIIbβ3 (Fig. S3 B). Immunoblotting
confirmed similar level of expression for all THD mutants
(Fig. S3 C).
Since we used the THD in our experiments, we alsowanted to
test the effect of the F1 mutants in full-length talin1. To ensure
maximal Rap1 activation, we expressed Rap1 (Q63E) in A5 cells
and noticed no increase in αIIbβ3 activation, consistent with the
modest levels of talin in these cells (Fig. S3 D), as previously
reported (Han et al., 2006). Coexpression of talin1 increased
activation, as did the talin1(R35E) mutant. Importantly, both
talin1(R118E) and talin1(ΔL) reduced integrin activation to a
similar extent. Indeed, the effect of the combined talin1(ΔL,
R35E,R118E) mutant was similar to that of talin1(R118E) alone,
emphasizing the critical role of Rap1 binding F1 and suggesting
that the Rap1 dependence of talin1-induced activation depends
on the loop in F1, thus explaining why F1 is more important than
F0 in this function.
Gingras et al. Journal of Cell Biology 1803
Talin F1–Rap1 binding in integrin activation https://doi.org/10.1083/jcb.201810061
Rap1 binding to THD F0 and F1 facilitates its recruitment to
paxillin-containing adhesions
To further evaluate the role of the Rap1–talin1 interaction in
integrin functions, we examined the recruitment of THD to
adhesion structures in adherent 3T3 fibroblasts. THD localized
to paxillin-positive adhesions (Fig. 5 A). A previous report re-
vealed the role of Rap1 binding to the F0 domain in talin1 re-
cruitment to adhesion sites (Zhu et al., 2017). Similarly, we
found that colocalization of THD(R35E) mutant with paxillin
was reduced (Fig. 5, A and B). Remarkably, THD(R118E) mutant
showed an even more impaired recruitment to paxillin-positive
adhesions (Fig. 5, A and B), resulting inmore diffuse cytoplasmic
localization. Thus, Rap1 binding to each Rap1 binding site in THD
is important for recruitment to paxillin-containing adhesions.
The studies reported here provide new insight into how ta-
lin1 activates integrins, a process central to mammalian devel-
opment and numerous physiological functions. Studies in A5
cells led to the conclusion that talin1 is required for integrin
activation, established the importance of specific structural el-
ements in the integrin and in THD, and identified the impor-
tance of lipid binding residues (Tadokoro et al., 2003; Wegener
et al., 2007; Anthis et al., 2009; Goult et al., 2010). The A5 cells
were also instrumental in studies that showed how Rap1, by
engaging RIAM, enabled RIAM to recruit talin1 to integrins (Han
et al., 2006; Lee et al., 2009), a key pathway in leukocyte traf-
ficking and formation of the immune synapse (Lagarrigue et al.,
2017). Nevertheless, Rap1 can activate integrins in the absence of
RIAM or obvious candidate effectors. Goult’s pioneering studies
suggested that talin1 F0 could enable talin1 to itself be an effector
(Goult et al., 2010), an idea further advanced by Zhu et al. (2017);
however, we found that the F0 domain made a minor contri-
bution in mammals. We now find that the F1 domain contains a
second Rap1-binding site and that this site functions in con-
junction with a unique inserted loop to enable Rap1 to regulate
activation. The proximity of the putative membrane-binding
helix of the F1 loop to the geranyl-geranyl moiety of Rap1
bound to F1 provides a cogent model to explain the comple-
mentary role of these two membrane-binding sites in integrin
activation (Fig. 5 C). Indeed, the now more complete picture of
how THD interacts with the membrane shows that an extended
series of membrane-binding sites (Fig. 5 D) serve to stabilize the
weak interaction of talin1 F3 with the integrin β cytoplasmic
domain to explain the membrane dependence of talin1-induced
activation (Ye et al., 2010). Our studies show how Rap1 can add
to those membrane-binding sites to enable activation.
Our studies raise several new questions. In mice, Rap1
binding to talin1 F0 is clearly dispensable for normal develop-
ment and has only a modest effect on activation of αIIbβ3 and
platelet function. In stark contrast, in D. discoideum (Plak et al.,
2016) and Drosophila (Camp et al., 2018), blocking Rap1 binding
to talin1 F0 has severe consequences for morphogenesis. We
note that D. discoideum TalinB F1 has no loop, and in Drosophila
talin, the loop sequence is not conserved, suggesting that evo-
lution has endowed mammalian F1 with a loop capable of
supporting most Rap1-dependent integrin function, even in
the absence of F0’s contribution. Absent this enhanced function
of F1, F0’s contribution may become indispensable. This hy-
pothesis will be testable by future reverse genetic studies in
Figure 3. F1 is responsible for THD Rap1-
dependent integrin activation. (A) THD con-
structs used in B–D. (B and C) A5 cells stably
expressing αIIbβ3 integrin were transfected with
cDNA encoding THD-EGFP in combination with
Rap1(Q63E) or Rap1GAP1. Integrin activation was
assayed by binding of PAC1 to EGFP-positive
cells. Transfection of EGFP alone was used as a
control. (B) Bar graphs represent mean ± SEM of
four independent experiments normalized to
THD(wt)-EGFP + mock. Two-way ANOVA with
Bonferroni post-test. Each condition was com-
pared with the respective mock control. *, P <
0.05; **, P < 0.01. (C) Activation indices were
normalized to the maximum value of THD(wt)-
EGFP and plotted as a function of EGFP MFI.
Graphs represent mean ± SEM of four indepen-
dent experiments. Curve fitting was performed
using the total one-site binding model in Prism
5.0. Two-way ANOVA with Bonferroni post-test.
Each mutant was compared with THD(wt). ***,
P < 0.01. (D)WB of THD-EGFP expression. Actin
was used as a loading control.
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which the developmental and physiological effects of Rap1-
binding–defective F1 mutations can be assessed alone or in
combination with Rap1-binding–defective F0 mutations. The
future reverse genetic experiments will also enable studies to
assess the importance of Rap1 binding to talin1 in cells, such as
leukocytes, that possess sufficient MRL (MIG-10, RIAM, and
Lamellipodin) proteins (e.g., RIAM) to provide an alternative
mechanism by which a Rap1 effector can engage talin1, leading
to its interaction with and activation of integrins. Finally, our
findings will enable future studies to characterize the role of
each of these Rap1-binding sites in activation in cells in which
talin1 and Rap1 are in varying abundance and assess their
roles in stability of integrin-mediated adhesions and resulting
mechanotransduction.
Materials and methods
Integrin activation in CHO cells
Cells were cultured in DMEM (Corning) supplemented with 10%
fetal bovine serum (Sigma-Aldrich) and 100 U/ml penicillin and
100 µg/ml streptomycin (Gibco). The sequences encoding mu-
rine THD (aa 1–433) or full-length talin1 were cloned into pEGFP-
N1 (Clontech). The sequences encoding human Rap1a(Q63E) and
Rap1GAP1 were cloned into p3xFlag7.1(−) (Sigma-Aldrich).
Transient transfection was performed using TransIT-LT1 Rea-
gent (Mirus) according to the manufacturer’s protocol. The
PAC-1–binding assay in A5 cells was conducted as previously
described (Frojmovic et al., 1991). Briefly, cells were harvested
by using trypsin 1 d after transfection and washed once in HBSS
buffer (containing calcium and magnesium; Gibco) supple-
mented with 1% (wt/vol) bovine serum albumin (Sigma-
Aldrich). PAC-1 IgM (ascites, 1:200) was incubated with cells for
30 min at room temperature before staining with the appro-
priate Alexa Fluor 647 secondary antibody (Life Technologies)
for 30min on ice. Cells were analyzed by flow cytometry using a
FACS Accuri C6 Plus (BD Biosciences) and gated on EGFP-
positive events. Integrin activation was defined as αIIbβ3-
specific ligand binding corrected for αIIbβ3 expression and
was calculated as 100 × ([MFI]i − MFI0)/ΔMFID57, where MFIi is
the mean fluorescence intensity (MFI) of bound PAC-1; MFI0 is
the MFI of bound PAC-1 in the presence of 10 µM Eptifibatide,
and ΔMFID57 is the specific fluorescence intensity of anti-αIIbβ3
D57 antibody. PAC1 (Shattil et al., 1985) and D57 (O’Toole et al.,
1994) antibodies have been previously described.
Protein expression and purification
Themurine talin1 residues 1–400 (THD), 84–400 (F1–F3), 84–196
(F1), and 84–196 Δ141–170 (F1 Δloop) were cloned into the ex-
pression vector pETM-11 (His tagged; EMBL) and expressed in
Escherichia coli BL21 Star (DE3) cultured in minimal medium for
15N-labeled samples for NMR or LB for unlabeled protein.
Briefly, recombinant His-tagged proteins was purified by nickel-
affinity chromatography, the His-tag removed by cleavage
with Tobacco Etch Virus protease overnight, and the protein
further purified by size exclusion chromatography using a
Superdex-75 (26/600) column (GE Healthcare). The columnwas
Figure 4. The F1-inserted loop with the
F1 Rap1-binding site work in tandem to pro-
mote integrin activation. (A) THD constructs
used in B and C. (B) A5 cells stably expressing
αIIbβ3 integrin were transfected with cDNA
encoding THD-EGFP in combination with
Rap1(Q63E) or Rap1GAP1. Integrin activation was
assayed by binding of PAC1 to EGFP-positive
cells. Transfection of EGFP alone was used as
control. Bar graphs represent mean ± SEM of
four independent experiments normalized to
THD(wt)-EGFP + mock. Two-way ANOVA with
Bonferroni post-test. Each condition was com-
pared with the respective mock control. *, P <
0.05; ***, P < 0.001. (C) WB of THD-EGFP
expression. Actin was used as a loading
control. (D) 2D 1H,15N-sfHMQC spectra of
100 µM 15N-labeled talin1 F1(ΔL) (blue) and in
the presence of 225 µM GMP.PNP Rap1b
(red). Specific chemical shift changes are
observed, indicating binding. (E) Close-up
view of the chemical shift changes for resi-
dues T96 and T99.
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Figure 5. The role of F1 in integrin activation: recruitment by Rap1 and phospholipids. (A) Airyscan laser scanning microscope images of maximum
intensity projections of 3T3 fibroblasts expressing both THD-EGFP (green) and mRby2-Paxillin (red). Bottom: Merged image and the paxillin-rich regions of
interest (red lines) with quantitative colocalization of both THD to paxillin in peripherally labeled paxillin-rich focal adhesions. The images clearly show a
diminishment of colocalized signal of THD to paxillin between the WT control and THD(R35E) mutant, which is further decreased in the THD(R118E) mutant.
Scale bar, 10 μM. (B) Quantitation results; the number of analyzed adhesions is indicated for each condition. All Mander’s colocalization coefficents obtained
were compared between WT and mutants as two tailed t tests displaying significant values on the graph. *, P < 0.05; **, P < 0.01. (C) A model of F1 in the
cytosol with a positively charged unstructured loop (green) and membrane-associated Rap1b-GTP by its C-terminal geranyl-geranyl (G-G) moiety (orange).
Negatively charged PI(4,5)P2 phospholipids are colored in red. On proximity of the plasma membrane, the low-affinity talin1 F1 RA domain probes for Rap1 and
the F1 loop seeks negatively charged phospholipids. On contact with Rap1 and negatively charged phospholipids, the F1 RA domain interacts with Rap1 and the
F1 loop helical state is favored, resulting in cluster of positive charges on one side of the helix. (D) View of the THD (green) as seen from the membrane is
displayed in the top right panel. Bottom: View of the THD as seen from the side. The views highlight the position of the THD F0, F1, F2, and F3 subdomains
(green) and Rap1b (orange) bound to the F0 and F1 subdomains. Both Rap1b C-terminal geranyl-geranyl moieties are pointing toward the membrane. Similarly,
the THD regions known to interact with the negatively charged phospholipids face the membrane (blue): the fly-casting F1 loop; the F2 membrane orientation
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preequilibrated and run with (NMR buffer) 20 mM sodium
phosphate, 50 mM NaCl, 3 mM MgCl2, and 2 mM DTT, pH 6.5.
The human Rap1 isoform Rap1b (residues 1–167) cloned into
pTAC vector in the E. coli strain CK600K was a generous gift
from Alfred Wittinghofer (Max Planck Institute of Molecular
Physiology, Dortmund, Germany). Untagged Rap1b was purified
by ion exchange, followed by Superdex-75 (26/600) gel filtration
as previously described (Gingras et al., 2016). The column was
preequilibrated and run with NMR buffer.
NMR spectroscopy
NMR samples of all the protein constructs were prepared in
NMR buffer containing 0.1 mM GMP.PNP and 5% (vol/vol)
of 2H2O. All 2D [1H,15N]-sfHMQC spectra were recorded at 298 K.
To test THD binding to Rap1b, 100 µM 15N-labeled GMP.PNP-
bound Rap1b was incubated with 250 µM unlabeled THD or
THD(ΔF0). Titration curves for the interaction of talin1 F1 with
GMP.PNP-bound Rap1bwere determined using 100 µM 15N-labeled
F1 in NMR buffer. Chemical shift changes (Δδobs (HN,N)) were
calculated using CcpNmr Analysis “follow shift changes” func-
tion, and analyzed with the one-site binding model to determine
the apparent Kd value in Prism 5.0 (GraphPad Software; Vranken
et al., 2005).
Western blotting (WB)
Cells were lysed in Laemmli sample buffer. Lysates were sub-
jected to a 4–20% gradient SDS-PAGE. Polyclonal serum directed
against EGFP was raised in rabbit (Abgent). Antibody against
β-actin (AC-15) was obtained from Sigma-Aldrich. The appro-
priate IRDye/Alexa Fluor–coupled secondary antibodies were
from LI-COR. Nitrocellulose membranes were scanned using an
Odyssey CLx infrared imaging system (LI-COR), and blots were
processed using Image Studio Lite software (LI-COR).
Microscopy
Flp-In 3T3 cells (Life Technologies) were cultured in DMEM
supplemented with 10% fetal bovine serum and 100 U/ml pen-
icillin and 100 µg/ml streptomycin. The sequence encoding
mRuby2 fused to the C terminus of Paxillin was cloned into the
pMSCV retroviral backbone (Addgene). Transduced mRuby2-
positive cells were single-cell cloned by automated cell deposi-
tion unit using a BD FACSAria (BD Biosciences). A selected clone
was then transfected with plasmids encoding EGFP fused to the
C terminus of murine THD (aa 1–433). THD-EGFP WT or mutant
sequences downstream of the Tet-On responsive element were
cloned into the pcDNA5/FRT plasmid (Life Technologies) ex-
pressing the Tet-On transactivator from the mouse phospho-
glycerate kinase promoter. Cells were cotransfected with
pcDNA5 constructs and the pOG44 Flp recombinase expression
vector using TransIT-LT1 (Mirus). Transformants were selected
in presence of 200 µg/ml of Hygromycin B (Life Technologies).
THD-EGFP expression was induced by adding 100 ng/ml
doxycycline (Sigma-Aldrich) overnight. Cells were trypsinized
and seeded on top of glass coverslips coated with 10 µg/ml hu-
man fibrinogen (Sigma-Aldrich). Cells were fixed 2 h later with
2% formaldehyde (Tousimis) for 20 min at 37°C, permeabilized
with Triton X-100, and stained with DAPI and Phalloidin con-
jugated to Alexa Fluor 647 (Life Technologies). 3D stacks of
images were acquired using a Zeiss laser scanning confocal
microscope Airy Scan 880, equipped with a 63× (1.46 NA) ob-
jective (using a 0.17-μm step interval) and an automated piezo
stage. Each image consisted of z-stacks of multiple frames that
were first processed from a raw Airyscan image to a final inte-
grated, corrected and deconvolved image that was then flattened
as a maximum intensity projection using ZEN software (Zeiss).
Only the optical two image slices that were closest to the cov-
erslip were projected in order to analyze localized proteins that
are on the basal surface of the cell: peripheral paxillin-rich ad-
hesions. The Images were then further processed in Image Pro
Premier 10 (IPP10; Media Cybernetics) in the following manner.
Maximum intensity projection images were calibrated and au-
totraced/masked for paxillin-rich signals using a smart seg-
mentation macro inherent in IPP10 that, based on control
images, was able to define all relevant paxillin-rich adhesions in
the cells and outline them. These masked outlines were used as
regions of interest from which a colocalization module in IPP10
autocalculated and displayed on the image (pseudocolored in
white) the amount of colocalization between paxiilin-rich zones
(red) and THD-rich zones (green) as seen in last panel of Fig. 5 A.
The relevant fluorescent signal range in the colocalization
module was 60–256 levels of gray, which was well above back-
ground controls. All colocalization values from IPP10 were ex-
ported directly into Excel, where they were further processed.
The experiment was repeated twice, examining on aver-
age 800 paxillin-rich adhesions over an average of 20 cells
per category.
Reagents
GMP.PNP was purchased from Sigma-Aldrich.
Statistical analysis
Statistical significance was assayed by a two-tailed t test for
single comparisons or ANOVA for multiple comparisons with a
Bonferroni post hoc test. A P value <0.05 was considered sig-
nificant. Data distribution was assumed to be normal, but this
was not formally tested.
Online supplemental material
Fig. S1 shows A5 cells stably expressing αIIbβ3 integrin trans-
fected with cDNA encoding THD(wt)-EGFP or THD(TM)-EGFP
or in the presence of MnCl2. Fig. S2 summarizes the effects of
Rap1 binding on the F1 by NMR spectroscopy. Fig. S3 shows the
effects of transfecting THD F1 loopmutants and full-length talin1
mutants in A5 cells.
patch (MOP); and the F3 association patch (FAP). The β-integrin transmembrane and cytoplasmic tail is shown in red bound to the F3 subdomain. Two Rap1b
(orange) molecules are shownwith their C-terminal geranyl-geranyl moiety inserted in the membrane. This model summarizes the multiple known interactions
of THD at the plasma membrane: the negatively charged PI(4,5)P2 phospholipids; two Rap1 molecules; and the integrin β-tails.
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